Literature DB >> 32234855

Complete remission of inoperable hepatic and bone metastases due to neuroendocrine pancreatic tumour 3 years after peptide receptor radionucleotide therapy.

Paula Soeiro1, Helder Martins2, Rodolfo Silva2,3, Ana Paula Moreira2,3.   

Abstract

Entities:  

Keywords:  cancer intervention; endocrine cancer; pancreatic cancer; radiology; therapeutic indications

Mesh：

Substances：

Year:  2020        PMID： 32234855      PMCID： PMC7167446          DOI： 10.1136/bcr-2019-233263

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  9 in total

Review 1.  Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors.

Authors:  John Ramage; Boris G Naraev; Thorvardur R Halfdanarson
Journal:  Semin Oncol       Date:  2018-10-24       Impact factor: 4.929

2.  Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.

Authors:  Jonathan Strosberg; Ghassan El-Haddad; Edward Wolin; Andrew Hendifar; James Yao; Beth Chasen; Erik Mittra; Pamela L Kunz; Matthew H Kulke; Heather Jacene; David Bushnell; Thomas M O'Dorisio; Richard P Baum; Harshad R Kulkarni; Martyn Caplin; Rachida Lebtahi; Timothy Hobday; Ebrahim Delpassand; Eric Van Cutsem; Al Benson; Rajaventhan Srirajaskanthan; Marianne Pavel; Jaime Mora; Jordan Berlin; Enrique Grande; Nicholas Reed; Ettore Seregni; Kjell Öberg; Maribel Lopera Sierra; Paola Santoro; Thomas Thevenet; Jack L Erion; Philippe Ruszniewski; Dik Kwekkeboom; Eric Krenning
Journal:  N Engl J Med       Date:  2017-01-12       Impact factor: 91.245

Review 3.  Carcinoid-syndrome: recent advances, current status and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-02       Impact factor: 3.243

Review 4.  Molecular radionuclide imaging of pancreatic neoplasms.

Authors:  Ananya Panda; Ishan Garg; Geoffrey B Johnson; Mark J Truty; Thorvardur R Halfdanarson; Ajit H Goenka
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-07

5.  Twelve-Year Follow-up After Peptide Receptor Radionuclide Therapy.

Authors:  Michael Gabriel; Bernhard Nilica; Bernhard Kaiser; Irene J Virgolini
Journal:  J Nucl Med       Date:  2018-08-16       Impact factor: 10.057

6.  The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours.

Authors:  L Bodei; J Mueller-Brand; R P Baum; M E Pavel; D Hörsch; M S O'Dorisio; T M O'Dorisio; T M O'Dorisiol; J R Howe; M Cremonesi; D J Kwekkeboom; John J Zaknun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05       Impact factor: 9.236

7.  ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.

Authors:  M Falconi; B Eriksson; G Kaltsas; D K Bartsch; J Capdevila; M Caplin; B Kos-Kudla; D Kwekkeboom; G Rindi; G Klöppel; N Reed; R Kianmanesh; R T Jensen
Journal:  Neuroendocrinology       Date:  2016-01-05       Impact factor: 4.914

8.  Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity.

Authors:  Ulrike Garske-Román; Mattias Sandström; Katarzyna Fröss Baron; Lars Lundin; Per Hellman; Staffan Welin; Silvia Johansson; Tanweera Khan; Hans Lundqvist; Barbro Eriksson; Anders Sundin; Dan Granberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-01       Impact factor: 9.236

9.  Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours.

Authors:  W A van der Zwan; T Brabander; B L R Kam; J J M Teunissen; R A Feelders; J Hofland; E P Krenning; W W de Herder
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-28       Impact factor: 9.236
  9 in total
  1 in total

Review 1.  Rare Bone Metastasis of Neuroendocrine Tumors of Unknown Origin: A Case Report and Literature Review.

Authors:  Qing Pan; Wenbo Yang; Zhicai Zhang; Zengwu Shao
Journal:  Orthop Surg       Date:  2022-07-20       Impact factor: 2.279
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.